Enrofloxacin and marbofloxacin in horses: Comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 5, 2006, Pages 337-344

  Peyrou, M ^a   Bousquet Melou, A ^b   Laroute, V ^b   Vrins, A ^c   Doucet, M Y ^c  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b CNRS   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; MARBOFLOXACIN; ZENIQUIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HORSE; KIDNEY CLEARANCE; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CIPROFLOXACIN; ENZYME INHIBITORS; FEMALE; FLUOROQUINOLONES; HALF-LIFE; HORSES; INJECTIONS, INTRAVENOUS; QUINOLONES;

BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 33748346632     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00752.x     Document Type: Article

References (28)

1. Bermingham, E.C., Papich, M.G. & Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706-709.
2. Bidgood, T.L. & Papich, M.G. (2005) Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 329-341.
3. Bousquet-Melou, A., Bernard, S., Schneider, M. & Toutain, P.L. (2002) Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal, 34, 366-372.
4. Carretero, M., Rodriguez, C., San Andres, M.I., Fores, P., de Lucas, J.J., Nieto, J., Waxman, S., San Andres, M.D. & Gonzalez, F. (2002) Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 34, 360-365.
5. Craig, W.A. (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1-10; quiz 11-2.
6. Dowling, P.M., Wilson, R.C., Tyler, J.W. & Duran, S.H. (1995) Pharmacokinetics of ciprofloxacin in ponies. Journal of Veterinary Pharmacology and Therapeutics, 18, 7-12.
7. EMEA (1996). Marbofloxacin - Summary Report of the Committee for Veterinary Medicinal Products. Document EMEA/MRL/079/96-Final. EMEA. Available at: http://www.emea.eu.int/pdfs/vet/mrls/007996en.pdf
8. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C. & Schentag, J.J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073-1081.
9. Gabrielsson, J. & Weiner, D. (2000) Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Swedish Pharmaceutical Press, Stockholm, Sweden.
10. Giguere, S. & Belanger, M. (1997) Concentration of enrofloxacin in equine tissues after long-term oral administration. Journal of Veterinary Pharmacology and Therapeutics, 20, 402-404.
11. Giguere, S., Sweeney, R.W. & Belanger, M. (1996) Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses. American Journal of Veterinary Research, 57, 1025-1030.
12. Griffiths, N.M., Hirst, B.H. & Simmons, N.L. (1994) Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin: a common secretory pathway? Journal of Pharmacology and Experimental Therapeutics, 269, 496-502.
13. Haines, G.R., Brown, M.P., Gronwall, R.R. & Merritt, K.A. (2000) Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares. Canadian Journal of Veterinary Research, 64, 171-177.
14. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. & Schentag, J.J. (1995) The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clinical Pharmacokinetics, 28, 143-160.
15. Kaartinen, L., Panu, S. & Pyorala, S. (1997) Pharmacokinetics of enro-floxacin in horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 29, 378-381.
16. Kukanich, B. & Papich, M.G. (2003) Fluoroquinolone Stability in Vehicles for Oral Administration. American College of Veterinary Internal Medicine Annual Forum, Charlotte, NC.
17. Kwan, K.C. (1997) Oral bioavailability and first-pass effects. Drug Metabolism and Disposition, 25, 1329-1336.
18. Langston, V.C., Sedrish, S. & Boothe, D.M. (1996) Disposition of singledose oral enrofloxacin in the horse. Journal of Veterinary Pharmacology and Therapeutics, 19, 316-319.
19. Meinen, J.B., McClure, J.T. & Rosin, E. (1995) Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. American Journal of Veterinary Research, 56, 1219-1224.
20. Papich, M.G., Van Camp, S.D., Cole, J.A. & Whitacre, M.D. (2002) Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. Journal of Veterinary Pharmacology and Therapeutics, 25, 343-350.
21. Peyrou, M., Doucet, M.Y., Vrins, A., Concordet, D., Schneider, M. & Bousquet-Melou, A. (2004) Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. Journal of Veterinary Pharmacology and Therapeutics, 27, 283-288.
22. Ramon, J., Ben-Haim, M., Shabtai, M. & Rubinstein, E. (2001) Transepithelial intestinal excretion of ciprofloxacin in humans. Clinical Infectious Diseases, 32, 822-823.
23. Riddle, C., Lemons, C.L., Papich, M.G. & Altier, C. (2000) Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing. Journal of Clinical Microbiology, 38, 1636-1637.
24. Rodvold, K.A. & Neuhauser, M. (2001) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy, 21, 233S-252S.
25. Rubinstein, E., Dautrey, S., Farinoti, R., St Julien, L., Ramon, J. & Carbon, C. (1995) Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats. Antimicrobial Agents and Chemotherapy, 39, 99-102.
26. Turnidge, J. (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs, 58, 29-36.
27. Weiss, M. (1988) A general model of metabolite kinetics following intravenous and oral administration of the parent drug. Biopharmaceutics and Drug Disposition, 9, 159-176.
28. Weiss, M. (1990) Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. Clinical Pharmacokinetics, 18, 419-422.